PUBMED FOR HANDHELDS

Journal Abstract Search


83 related items for PubMed ID: 9589380

  • 21. Association between cyclosporine concentrations at 2 hours post-dose and clinical outcomes in de novo lung transplant recipients.
    Akhlaghi F, Gonzalez L, Trull AK.
    J Heart Lung Transplant; 2005 Dec; 24(12):2120-8. PubMed ID: 16364860
    [Abstract] [Full Text] [Related]

  • 22. Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients.
    Holm T, Andreassen AK, Aukrust P, Andersen K, Geiran OR, Kjekshus J, Simonsen S, Gullestad L.
    Eur Heart J; 2001 Mar; 22(5):428-36. PubMed ID: 11207085
    [Abstract] [Full Text] [Related]

  • 23. Outcome of renal transplants from pediatric donors <5 yr of age.
    El-Sabrout R, Buch K.
    Clin Transplant; 2005 Jun; 19(3):316-20. PubMed ID: 15877791
    [Abstract] [Full Text] [Related]

  • 24. The area under the concentration-time curve versus trough and peak blood level monitoring in renal transplant recipients on cyclosporine.
    Halim MA, Nampoory MR, Johny KV, Donia F, Hamid MH, Said T, Nair MP, Mansour M, Al-Muzairai I, Samhan M, Al-Mousawi M.
    Transplant Proc; 2005 Sep; 37(7):3019-21. PubMed ID: 16213291
    [Abstract] [Full Text] [Related]

  • 25. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 26. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
    Madsen T, Schmidt EB, Christensen JH.
    J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 28. Renal transplants with delayed graft function show decreased renal function despite monitoring with postabsorptive levels.
    Dominguez J, Gonzalez A, Crossley N, Norambuena R.
    Transplant Proc; 2004 May; 36(6):1655-8. PubMed ID: 15350442
    [Abstract] [Full Text] [Related]

  • 29. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation.
    Trompeter R, Filler G, Webb NJ, Watson AR, Milford DV, Tyden G, Grenda R, Janda J, Hughes D, Ehrich JH, Klare B, Zacchello G, Bjorn Brekke I, McGraw M, Perner F, Ghio L, Balzar E, Friman S, Gusmano R, Stolpe J.
    Pediatr Nephrol; 2002 Mar; 17(3):141-9. PubMed ID: 11956848
    [Abstract] [Full Text] [Related]

  • 30. Cyclosporine-induced hypertension. Efficacy of omega-3 fatty acids in patients after cardiac transplantation.
    Ventura HO, Milani RV, Lavie CJ, Smart FW, Stapleton DD, Toups TS, Price HL.
    Circulation; 1993 Nov; 88(5 Pt 2):II281-5. PubMed ID: 8222166
    [Abstract] [Full Text] [Related]

  • 31. Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients.
    Boots JM, van Duijnhoven EM, Christiaans MH, Nieman FH, van Suylen RJ, van Hooff JP.
    Transpl Int; 2001 Dec; 14(6):370-83. PubMed ID: 11793034
    [Abstract] [Full Text] [Related]

  • 32. Immunosuppression in live-related donor renal transplantation.
    Iman A, Rao M, Juneja R, Jacob CK.
    Natl Med J India; 2001 Dec; 14(2):75-80. PubMed ID: 11396322
    [Abstract] [Full Text] [Related]

  • 33. Effect of fish oil on oxidative stress, lipid profile and renal function in IgA nephropathy.
    Parinyasiri U, Ong-Ajyooth L, Parichatikanond P, Ong-Ajyooth S, Liammongkolkul S, Kanyog S.
    J Med Assoc Thai; 2004 Feb; 87(2):143-9. PubMed ID: 15061297
    [Abstract] [Full Text] [Related]

  • 34. Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids: a prospective, double-blind, randomized study.
    Pettersson EE, Rekola S, Berglund L, Sundqvist KG, Angelin B, Diczfalusy U, Björkhem I, Bergström J.
    Clin Nephrol; 1994 Apr; 41(4):183-90. PubMed ID: 8026109
    [Abstract] [Full Text] [Related]

  • 35. Enhanced clinical utility of de novo cyclosporine C2 monitoring after lung transplantation.
    Morton JM, Aboyoun CL, Malouf MA, Plit ML, Glanville AR.
    J Heart Lung Transplant; 2004 Sep; 23(9):1035-9. PubMed ID: 15454168
    [Abstract] [Full Text] [Related]

  • 36. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation.
    Mino Y, Naito T, Matsushita T, Otsuka A, Ushiyama T, Ozono S, Hishida A, Kagawa Y, Kawakami J.
    Ther Drug Monit; 2008 Dec; 30(6):656-61. PubMed ID: 18978521
    [Abstract] [Full Text] [Related]

  • 37. Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial.
    Meier M, Nitschke M, Weidtmann B, Jabs WJ, Wong W, Suefke S, Steinhoff J, Fricke L.
    Transplantation; 2006 Apr 15; 81(7):1035-40. PubMed ID: 16612281
    [Abstract] [Full Text] [Related]

  • 38. The clinical impact of 1:1 conversion from Neoral to a generic cyclosporine (Gengraf) in renal transplant recipients with stable graft function.
    Qazi YA, Forrest A, Tornatore K, Venuto RC.
    Clin Transplant; 2006 Apr 15; 20(3):313-7. PubMed ID: 16824147
    [Abstract] [Full Text] [Related]

  • 39. Glipizide treatment of post-transplant diabetes does not interfere with cyclosporine pharmacokinetics in renal allograft recipients.
    Sagedal S, Asberg A, Hartmann A, Bergan S, Berg KJ.
    Clin Transplant; 1998 Dec 15; 12(6):553-6. PubMed ID: 9850449
    [Abstract] [Full Text] [Related]

  • 40. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, Homan van der Heide JJ, de Fijter HW.
    Transplantation; 2009 Aug 15; 88(3):421-8. PubMed ID: 19667948
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.